Issue 3/2012
Content (30 Articles)
The IL-10 promoter haplotype and cancer risk: evidence from a meta-analysis
Kui Zhang, Lushun Zhang, Xianmin Wang, Lin Zhang
French experts report on MUTYH-associated polyposis (MAP)
Bruno Buecher, Catherine Bonaïti, Marie-Pierre Buisine, Chrystelle Colas, Jean-Christophe Saurin
Common MUTYH mutations and colorectal cancer risk in multiethnic populations
Flavio Lejbkowicz, Ilana Cohen, Ofra Barnett-Griness, Mila Pinchev, Jen Poynter, Stephen B. Gruber, Gad Rennert
A prospective study of bowel preparation for colonoscopy with polyethylene glycol-electrolyte solution versus sodium phosphate in Lynch syndrome: a randomized trial
Maria W. J. van Vugt van Pinxteren, Mariëtte C. A. van Kouwen, Martijn G. H. van Oijen, Theo van Achterberg, Fokko M. Nagengast
Adequacy of family history taking in ovarian cancer patients: a population-based study
Anne M. van Altena, Sandra van Aarle, Lambertus A. L. M. Kiemeney, Nicoline Hoogerbrugge, Leon F. A. G. Massuger, Joanne A. de Hullu
Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases
Izabela Brozek, Magdalena Ratajska, Magdalena Piatkowska, Anna Kluska, Aneta Balabas, Michalina Dabrowska, Dorota Nowakowska, Anna Niwinska, Jadwiga Rachtan, Jan Steffen, Janusz Limon
Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromes
Adam Andreasson, Luqman Sulaiman, Sónia do Vale, João Martin Martins, Florbela Ferreira, Gabriel Miltenberger-Miltenyi, Lucas Batista, Felix Haglund, Erik Björck, Inga-Lena Nilsson, Anders Höög, Catharina Larsson, C. Christofer Juhlin
Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance
Irma Kluijt, Rolf H. Sijmons, Nicoline Hoogerbrugge, John T. Plukker, Daphne de Jong, J. Han van Krieken, Richard van Hillegersberg, Marjolijn Ligtenberg, Eveline Bleiker, Anemieke Cats
The use of telephone in genetic counseling versus in-person counseling: a randomized study on counselees’ outcome
Ulla Platten, Johanna Rantala, Annika Lindblom, Yvonne Brandberg, Gunilla Lindgren, Brita Arver
Mutation screening of RAD51C in high-risk breast and ovarian cancer families
Wenping Lu, Xianshu Wang, Hongsheng Lin, Noralane M. Lindor, Fergus J. Couch
Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma; clinicopathological long-term follow-up
C. A. Jilg, Hartmut P. H. Neumann, S. Gläsker, O. Schäfer, C. Leiber, P. U. Ardelt, M. Schwardt, W. Schultze-Seemann
Uroepithelial and kidney carcinoma in Lynch syndrome
Markku Aarnio, Matti Säily, Matti Juhola, Annette Gylling, Päivi Peltomäki, Heikki J. Järvinen, Jukka-Pekka Mecklin
The consequences of risk reducing salpingo-oophorectomy: the case for a coordinated approach to long-term follow up post surgical menopause
Carmel Pezaro, Paul James, Joanne McKinley, Mary Shanahan, Mary-Anne Young, Gillian Mitchell
Ameloblastoma: a neglected criterion for nevoid basal cell carcinoma (Gorlin) syndrome
Giovanni Ponti, Lorenza Pastorino, Annamaria Pollio, Sabina Nasti, Giovanni Pellacani, Michele D. Mignogna, Aldo Tomasi, Corrado Del Forno, Caterina Longo, Giovanna Bianchi-Scarrà, Guido Ficarra, Stefania Seidenari
A multidisciplinary clinic for individualizing management of patients at increased risk for breast and gynecologic cancer
Natalie J. Engel, Patricia Gordon, Darcy L. Thull, Beth Dudley, Judy Herstine, Rachel C. Jankowitz, Kristin K. Zorn
Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations
Monique A. de Bruin, Ava Kwong, Benjamin A. Goldstein, Jafi A. Lipson, Debra M. Ikeda, Lisa McPherson, Bhavna Sharma, Ani Kardashian, Elizabeth Schackmann, Kerry E. Kingham, Meredith A. Mills, Dee W. West, James M. Ford, Allison W. Kurian
Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry
Mala Pande, Chongjuan Wei, Jinyun Chen, Christopher I. Amos, Patrick M. Lynch, Karen H. Lu, Laura A. Lucio, Stephanie G. Boyd-Rogers, Sarah A. Bannon, Maureen E. Mork, Marsha L. Frazier
Closing the loop: an interactive action-research conference format for delivering updated medical information while eliciting Latina patient/family experiences and psychosocial needs post-genetic cancer risk assessment
Deborah J. MacDonald, Julia Deri, Charité Ricker, Martin A. Perez, Raquel Ogaz, Nancy Feldman, Lori A. Viveros, Benjamin Paz, Jeffrey N. Weitzel, Kathleen R. Blazer
Microsatellite instability testing in Korean patients with colorectal cancer
Jung Ryul Oh, Duck-Woo Kim, Hye Seung Lee, Hee Eun Lee, Sung Min Lee, Je-Ho Jang, Sung-Bum Kang, Ja-Lok Ku, Seung-Yong Jeong, Jae-Gahb Park
Causes of death of mutation carriers in Finnish Lynch syndrome families
Kirsi Pylvänäinen, Tuula Lehtinen, Ilmo Kellokumpu, Heikki Järvinen, Jukka-Pekka Mecklin
Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome
Pascale This, Anne de la Rochefordière, Alexia Savignoni, Marie Christine Falcou, Anne Tardivon, Fabienne Thibault, Séverine Alran, Virgine Fourchotte, Alfred Fitoussi, Benoit Couturaud, Sylvie Dolbeault, Remy J. Salmon, Brigitte Sigal-Zafrani, Bernard Asselain, Dominique Stoppa-Lyonnet
Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families
Irene Catucci, Roni Milgrom, Anya Kushnir, Yael Laitman, Shani Paluch-Shimon, Sara Volorio, Filomena Ficarazzi, Loris Bernard, Paolo Radice, Eitan Friedman, Paolo Peterlongo
Outcomes of a systems-level intervention offering breast cancer risk assessments to low-income underserved women
Darren Mays, McKane E. Sharff, Tiffani A. DeMarco, Bernice Williams, Beth Beck, Vanessa B. Sheppard, Beth N. Peshkin, Jennifer Eng-Wong, Kenneth P. Tercyak
High prevalence of the c.1227_1228dup (p.Glu410GlyfsX43) mutation in Tunisian families affected with MUTYH-associated-polyposis
Rania Abdelmaksoud-Dammak, Imen Miladi-Abdennadher, Ali Amouri, Nabil Tahri, Lobna Ayadi, Abdelmajid Khabir, Foued Frikha, Ali Gargouri, Raja Mokdad-Gargouri
Clinical correlation and molecular evaluation confirm that the MLH1 p.Arg182Gly (c.544A>G) mutation is pathogenic and causes Lynch syndrome
Michael P. Farrell, David J. Hughes, Ian R. Berry, David J. Gallagher, Emily A. Glogowski, Stewart J. Payne, Michael J. Kennedy, Róisín M. Clarke, Susan A. White, Cian B. Muldoon, Fiona Macdonald, Pauline Rehal, Danielle Crompton, Solvig Roring, Sarah T. Duke, Trudi McDevitt, David E. Barton, Shirley V. Hodgson, Andrew J. Green, Peter A. Daly
Q48P mutation in the hMLH1 gene associated with Lynch syndrome in three Hungarian families
Miklós Tanyi, Judit Olasz, Janos L. Tanyi, László Tóth, Péter Antal-Szalmás, Tamás Bubán, Csilla András, Hilda Urbancsek, Zoltán Garami, Orsolya Csuka, László Damjanovich
Analysis of a Finnish family confirms RHBDF2 mutations as the underlying factor in tylosis with esophageal cancer
Silva Saarinen, Pia Vahteristo, Rainer Lehtonen, Kristiina Aittomäki, Virpi Launonen, Tuula Kiviluoto, Lauri A. Aaltonen
Hepatoblastoma in two siblings and familial adenomatous polyposis: causal nexus or coincidence?
Christina Evers, Harald Gaspar, Matthias Kloor, Gergana Bozukova, Martina Kadmon, Monika Keller, Christian Sutter, Ute Moog
Novel germline c-MET mutation in a family with hereditary papillary renal carcinoma
Karin A. W. Wadt, Anne-Marie Gerdes, Thomas V. O. Hansen, Birgitte G. Toft, Lennart Friis-Hansen, Mette K. Andersen
The evolution of personalized cancer genetic counseling in the era of personalized medicine
Hetal S. Vig, Catharine Wang